CVE:BRM BioRem (BRM) Stock Price, News & Analysis C$3.12 +0.02 (+0.65%) As of 06/26/2026 12:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About BioRem Stock (CVE:BRM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioRem alerts:Sign Up Key Stats Today's RangeC$3.06▼C$3.1250-Day RangeC$2.50▼C$3.5452-Week RangeC$1.87▼C$3.57Volume11,116 shsAverage Volume25,930 shsMarket CapitalizationC$50.65 millionP/E Ratio11.60Dividend Yield6.47%Price TargetN/AConsensus RatingN/A Company Overview BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada. Read More Receive BRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BRM Stock News HeadlinesAndina, BioRem, Cavvy at 52-Week High on NewsMay 14, 2026 | baystreet.caBiorem Reports $65.3 Million Order BacklogApril 20, 2026 | finance.yahoo.comStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. | Porter & Company (Ad)BioRem Inc.'s (CVE:BRM) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?October 25, 2025 | finance.yahoo.comBiorem Reports Record Revenues and Earnings before tax for 2024 and Again Reports Record Order BacklogApril 17, 2025 | finance.yahoo.comBRM:CA BioRem Inc.March 20, 2025 | seekingalpha.comAre Robust Financials Driving The Recent Rally In BioRem Inc.'s (CVE:BRM) Stock?February 17, 2025 | finance.yahoo.comBIOREM Announces Orders Totalling $8 Million and Order Backlog of $60.5 MillionFebruary 11, 2025 | finance.yahoo.comSee More Headlines BRM Stock Analysis - Frequently Asked Questions How have BRM shares performed this year? BioRem's stock was trading at C$2.70 at the start of the year. Since then, BRM stock has increased by 15.6% and is now trading at C$3.12. How were BioRem's earnings last quarter? BioRem Inc. (CVE:BRM) released its earnings results on Wednesday, November, 6th. The company reported $0.12 earnings per share (EPS) for the quarter. BioRem had a trailing twelve-month return on equity of 37.34% and a net margin of 11.21%. How do I buy shares of BioRem? Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of BioRem own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and Company Calendar Last Earnings11/06/2024Today6/26/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorIndustrials Industry Pollution & Treatment Controls Sub-IndustryPharmaceutical Products Current SymbolCVE:BRM CIKN/A Webwww.biorem.biz Phone+1-519-7679100FaxN/AEmployees34,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.27 Trailing P/E Ratio11.60 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$5.40 million Net Margins11.21% Pretax MarginN/A Return on Equity37.34% Return on Assets14.61% Debt Debt-to-Equity Ratio17.32 Current Ratio2.02 Quick Ratio1.08 Sales & Book Value Annual SalesC$44.44 million Price / Sales1.14 Cash FlowC$0.84 per share Price / Cash Flow3.70 Book ValueC$0.95 per share Price / Book3.29Miscellaneous Outstanding Shares16,235,000Free FloatN/AMarket CapC$50.65 million OptionableNot Optionable Beta0.84 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (CVE:BRM) was last updated on 6/27/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
